glp 1 and gallbladder disease GLP1 I want to talk about GLP-1 medications and gallbladder disease, because this is an area where I see a lot of confusion and, honestly, a lot of patients missing out on GLP-1 Receptor Agonists | New

Children under age 18 must have at least one weight-related health condition and their BMI must be in the 95th percentile for their age and sex based on current Centers for Disease Control and Prevention (CDC) charts

Many patients could benefit

M., LaSalle, J

While this helps with appetite suppression and weight loss, it can also lead to bloating, nausea, and digestive discomfort

Up to 63% of type 2 diabetes patients on GLP-1 RAs reach healthy blood sugar levels after at least 12 weeks

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management, chronic weight management, and in the case of Wegovy, cardiovascular risk reduction in certain patients